Melissa Wagner-Schuman, MD, PhD, is affiliated with the Department of Psychiatry and Behavioral Neuroscience at the University of Cincinnati College of Medicine. Her publications focus on mood disorders, including anxiety, bipolar disorder, and major depressive disorder, with particular attention to treatment preferences among women and therapeutic approaches for premenstrual dysphoric disorder. She has contributed to research on practical guidelines and risk-benefit analyses for long-term hormone-based therapies. Her work appears in Psychiatrist.com, collaborating frequently with Alyssa Kania, Ashley Mulvihill, Diana I. Simeonova, Heather A. Flynn, and Jaclyn M. Ross.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
